샘플 요청 목록

 카트 문의
시장보고서
상품코드
1874465

세계의 의약품 1차 내부 포장 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

Pharmaceutical Primary Inner Packaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 의약품 1차 내부 포장 시장 규모는 2024년에 412억 5,500만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 5.4%로 성장하여 2031년까지 599억 3,800만 달러에 달할 것으로 예측됩니다.

의약품 1차 내부 포장이란 의약품(약품, 백신, 기타 의료제품 등)과 직접 접촉하는 재료 및 용기를 말합니다. 이 포장은 오염, 습기, 빛, 공기, 물리적 손상과 같은 외부 요인으로부터 제품을 보호하는 동시에 제품이 유효 기간 동안 유효성, 안정성, 안전성을 유지하도록 보장하도록 설계되었습니다.

최근 몇 년 동안 세계 의약품 1차 내부 포장 시장은 꾸준한 성장세를 유지하고 있으며, 그 주요 요인은 바이오 의약품 산업의 확대, 혁신 의약품 연구개발 가속화, 제네릭 의약품에 대한 수요 증가에 기인합니다. 이 중 프리필드시린지(PFS), 바이알, 앰플, 블리스 터 포장이 주류를 이루고 있으며, 생분해성 소재와 스마트 패키징이 새로운 트렌드로 떠오르고 있습니다.

의약품 1차 내부 포장의 주요 수요처는 주사제, 생물학적 제제, 경구용 고형제제이며, 특히 단일클론항체, mRNA 백신 등 바이오 의약품의 등장으로 고차폐성, 저흡착성 포장재에 대한 수요가 증가하고 있습니다. 또한, 맞춤형 의료와 재택의료의 추세에 따라 소량포장(1회용 점안제, 프리필드 주사펜 등) 시장이 성장하고 있습니다.

지역별로 살펴보면:

미국은 강력한 바이오 제약 산업과 엄격한 FDA 규제로 인해 고기능성 1차 포장재(무균 주사기, 특수 폴리머 병 등)에 대한 수요를 주도하고 있습니다. 유럽 시장은 성숙하고, 독일, 스위스 등 국가에서는 고부가가치 의약품이 고규격 유리병과 고무 씰에 의존하고 있습니다. EU의 지속 가능한 개발 규정(SUPD 등)은 재활용 가능한 알루미늄-플라스틱 복합 필름과 바이오플라스틱의 적용을 촉진하고 있습니다. 아시아태평양은 가장 빠른 성장세를 보이고 있습니다. 중국과 인도는 제네릭 의약품 수출과 국내 혁신 의약품의 부상으로 유리 앰플과 플라스틱 필름에 대한 수요가 급증하고 있습니다. 일본의 고령화 사회로 인해 편리한 포장(예를 들어, 자를 수 있는 알루미늄 포일) 시장 잠재력은 매우 크다고 할 수 있습니다.

시장 개척의 기회:

단일클론항체, 세포치료제 등에는 초저흡착 포장재가 요구되고 있으며, 맞춤형 솔루션이 탄생하고 있습니다. EU의 '그린 딜'과 FDA의 재활용성 가이드라인은 생분해성 포장재 개발을 촉진하고 있습니다. IoT(온도 기록 라벨 등)의 통합은 특히 콜드체인에 의존하는 백신의 경우 의약품의 추적성을 향상시킵니다. 동남아시아(인도네시아, 베트남 등)의 GMP 인증의 고도화는 포장재 공급업체에게 새로운 성장 기회를 제공합니다.

시장 리스크와 과제:

원자재 가격 변동: 붕규산 유리는 천연가스 에너지에 의존하고 있으며(유럽의 에너지 위기로 인해 비용 압박이 증가), 규제 장벽: USP<:660:gt;& 및 EU 약전(E&:L)의 추출물/용출물(E&:L)에 대한 요구사항이 엄격해짐에 따라 중소기업의 중소기업의 컴플라이언스 비용이 증가하고 있습니다. 대체 기술의 위협: 포장 불필요 기술(동결건조 경구용 정제 등)은 기존 포장에 대한 수요를 감소시킬 수 있습니다.

이 보고서는 의약품 1차 내부 포장 세계 시장에 대해 총 매출액, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

의약품 1차 내부 포장 시장 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020년에서 2031년까지의 기간 동안의 과거 데이터와 예측 데이터를 포함하는 매출액으로 제공되었습니다. 정량적 분석과 정성적 분석을 통해 독자들이 비즈니스/성장 전략을 수립하고, 시장 경쟁 구도를 평가하고, 현재 시장에서의 위치를 분석하고, 의약품 1차 내부 포장 관련 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.

시장 세분화

기업별

  • West Pharmaceutical Services
  • Gerresheimer
  • AptarGroup
  • Stevanato Group
  • Amcor
  • Shandong Pharmaceutical
  • Constantia Flexibles
  • Schott Pharma
  • Berry Global
  • SGD Pharma
  • Nipro
  • Shandong Weigao Group
  • BD
  • HySum
  • Chengdu Jingu Pharma-Pack Co.,Ltd
  • Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
  • Gerresheimer Shuangfeng
  • Jinghua Group
  • Linuo Pharmaceutical Packaging
  • Jiyuan Zhengyu
  • EHUA

유형별 부문

  • 유리 포장
  • 플라스틱 포장
  • 금속 포장

용도별 부문

  • 바이오의약품
  • 화학 의약품

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동 및 아프리카
LSH

자주 묻는 질문

  • 2024년 의약품 1차 내부 포장 시장 규모는 어떻게 되나요?
  • 의약품 1차 내부 포장 시장의 주요 수요처는 무엇인가요?
  • 의약품 1차 내부 포장 시장의 주요 기업은 어디인가요?
  • 의약품 1차 내부 포장 시장의 지역별 특징은 무엇인가요?
  • 의약품 1차 내부 포장 시장의 성장 기회는 무엇인가요?
  • 의약품 1차 내부 포장 시장의 리스크와 과제는 무엇인가요?

The global market for Pharmaceutical Primary Inner Packaging was estimated to be worth US$ 41255 million in 2024 and is forecast to a readjusted size of US$ 59938 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.

Pharmaceutical Primary Inner Packaging refers to the materials and containers that come into direct contact with the pharmaceutical product (such as drugs, vaccines, or other medical products). This packaging is designed to protect the product from external factors like contamination, moisture, light, air, and physical damage while also ensuring that the product maintains its efficacy, stability, and safety throughout its shelf life.

In recent years, the global Pharmaceutical Primary Inner Packaging market has maintained steady growth, mainly driven by the expansion of the biopharmaceutical industry, the acceleration of innovative drug research and development, and the rising demand for generic drugs. Among them, prefilled syringes (PFS), vials, ampoules and blister packaging dominate, while biodegradable materials and smart packaging have become emerging trends.

The core demand for Pharmaceutical Primary Inner Packaging comes from injections, biologics and oral solid preparations, especially the rise of biopharmaceuticals such as monoclonal antibodies and mRNA vaccines, which has driven the demand for high-barrier and low-adsorption packaging materials. In addition, the trend of personalized medicine and home medication has led to the growth of the market for small-dose packaging (such as single-dose eye drops and prefilled injection pens).

Regionally:

The United States, with its strong biopharmaceutical industry and strict FDA regulations, is driving demand for high-end primary packaging materials (such as sterile syringes and specialty polymer bottles). The European market is mature, and high-value-added drugs in countries such as Germany and Switzerland rely on high-specification glass bottles and rubber seals. The EU's sustainable development regulations (such as SUPD) promote the application of recyclable aluminum-plastic composite films and bio-based plastics. The Asia-Pacific region has the fastest growth. China and India have benefited from the export of generic drugs and the rise of local innovative drugs, and the demand for glass ampoules and plastic films has surged. Due to the aging society in Japan, the market potential for convenient packaging (such as tear-off aluminum foil) is huge.

Market development opportunities:

Monoclonal antibodies, cell therapies, etc. require ultra-low adsorption packaging materials, giving rise to customized solutions. The EU's "Green Deal" and FDA's recyclability guidelines have driven companies to develop biodegradable packaging materials. Internet of Things (IoT) integration (such as temperature recording labels) improves drug traceability, especially for cold chain-dependent vaccines. GMP certification upgrades in Southeast Asia (such as Indonesia and Vietnam) provide new growth points for packaging material suppliers.

Market risks and challenges:

Raw material fluctuations: Borosilicate glass is dependent on natural gas energy (European energy crisis exacerbates cost pressure). Regulatory barriers: USP<660> and EU EP have stricter requirements on extractables/leachables (E&L), and the compliance costs of small and medium-sized enterprises are rising. Substitution threats: Packaging-free technologies (such as freeze-dried oral tablets) may reduce the demand for traditional packaging.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Primary Inner Packaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Primary Inner Packaging by region & country, by Type, and by Application.

The Pharmaceutical Primary Inner Packaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Primary Inner Packaging.

Market Segmentation

By Company

  • West Pharmaceutical Services
  • Gerresheimer
  • AptarGroup
  • Stevanato Group
  • Amcor
  • Shandong Pharmaceutical
  • Constantia Flexibles
  • Schott Pharma
  • Berry Global
  • SGD Pharma
  • Nipro
  • Shandong Weigao Group
  • BD
  • HySum
  • Chengdu Jingu Pharma-Pack Co.,Ltd
  • Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
  • Gerresheimer Shuangfeng
  • Jinghua Group
  • Linuo Pharmaceutical Packaging
  • Jiyuan Zhengyu
  • EHUA

Segment by Type

  • Glass Packaging
  • Plastic Packaging
  • Metal Packaging

Segment by Application

  • Biopharmaceuticals
  • Chemical Pharmaceuticals

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pharmaceutical Primary Inner Packaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pharmaceutical Primary Inner Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pharmaceutical Primary Inner Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pharmaceutical Primary Inner Packaging Product Introduction
  • 1.2 Global Pharmaceutical Primary Inner Packaging Market Size Forecast (2020-2031)
  • 1.3 Pharmaceutical Primary Inner Packaging Market Trends & Drivers
    • 1.3.1 Pharmaceutical Primary Inner Packaging Industry Trends
    • 1.3.2 Pharmaceutical Primary Inner Packaging Market Drivers & Opportunity
    • 1.3.3 Pharmaceutical Primary Inner Packaging Market Challenges
    • 1.3.4 Pharmaceutical Primary Inner Packaging Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pharmaceutical Primary Inner Packaging Players Revenue Ranking (2024)
  • 2.2 Global Pharmaceutical Primary Inner Packaging Revenue by Company (2020-2025)
  • 2.3 Key Companies Pharmaceutical Primary Inner Packaging Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Pharmaceutical Primary Inner Packaging Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Primary Inner Packaging
  • 2.6 Pharmaceutical Primary Inner Packaging Market Competitive Analysis
    • 2.6.1 Pharmaceutical Primary Inner Packaging Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Primary Inner Packaging Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Primary Inner Packaging as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Glass Packaging
    • 3.1.2 Plastic Packaging
    • 3.1.3 Metal Packaging
  • 3.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Type
    • 3.2.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pharmaceutical Primary Inner Packaging Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pharmaceutical Primary Inner Packaging Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biopharmaceuticals
    • 4.1.2 Chemical Pharmaceuticals
  • 4.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Application
    • 4.2.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pharmaceutical Primary Inner Packaging Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pharmaceutical Primary Inner Packaging Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Region
    • 5.1.1 Global Pharmaceutical Primary Inner Packaging Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2020-2025)
    • 5.1.3 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (2026-2031)
    • 5.1.4 Global Pharmaceutical Primary Inner Packaging Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.2.2 North America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.3.2 Europe Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Pharmaceutical Primary Inner Packaging Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.5.2 South America Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Pharmaceutical Primary Inner Packaging Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.3.2 United States Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.4.2 Europe Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.5.2 China Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.6.2 Japan Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.7.2 South Korea Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pharmaceutical Primary Inner Packaging Sales Value, 2020-2031
    • 6.9.2 India Pharmaceutical Primary Inner Packaging Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pharmaceutical Primary Inner Packaging Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 West Pharmaceutical Services
    • 7.1.1 West Pharmaceutical Services Profile
    • 7.1.2 West Pharmaceutical Services Main Business
    • 7.1.3 West Pharmaceutical Services Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.1.4 West Pharmaceutical Services Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.1.5 West Pharmaceutical Services Recent Developments
  • 7.2 Gerresheimer
    • 7.2.1 Gerresheimer Profile
    • 7.2.2 Gerresheimer Main Business
    • 7.2.3 Gerresheimer Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.2.4 Gerresheimer Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Gerresheimer Recent Developments
  • 7.3 AptarGroup
    • 7.3.1 AptarGroup Profile
    • 7.3.2 AptarGroup Main Business
    • 7.3.3 AptarGroup Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.3.4 AptarGroup Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.3.5 AptarGroup Recent Developments
  • 7.4 Stevanato Group
    • 7.4.1 Stevanato Group Profile
    • 7.4.2 Stevanato Group Main Business
    • 7.4.3 Stevanato Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.4.4 Stevanato Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Stevanato Group Recent Developments
  • 7.5 Amcor
    • 7.5.1 Amcor Profile
    • 7.5.2 Amcor Main Business
    • 7.5.3 Amcor Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.5.4 Amcor Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Amcor Recent Developments
  • 7.6 Shandong Pharmaceutical
    • 7.6.1 Shandong Pharmaceutical Profile
    • 7.6.2 Shandong Pharmaceutical Main Business
    • 7.6.3 Shandong Pharmaceutical Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.6.4 Shandong Pharmaceutical Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Shandong Pharmaceutical Recent Developments
  • 7.7 Constantia Flexibles
    • 7.7.1 Constantia Flexibles Profile
    • 7.7.2 Constantia Flexibles Main Business
    • 7.7.3 Constantia Flexibles Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.7.4 Constantia Flexibles Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Constantia Flexibles Recent Developments
  • 7.8 Schott Pharma
    • 7.8.1 Schott Pharma Profile
    • 7.8.2 Schott Pharma Main Business
    • 7.8.3 Schott Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.8.4 Schott Pharma Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Schott Pharma Recent Developments
  • 7.9 Berry Global
    • 7.9.1 Berry Global Profile
    • 7.9.2 Berry Global Main Business
    • 7.9.3 Berry Global Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.9.4 Berry Global Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Berry Global Recent Developments
  • 7.10 SGD Pharma
    • 7.10.1 SGD Pharma Profile
    • 7.10.2 SGD Pharma Main Business
    • 7.10.3 SGD Pharma Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.10.4 SGD Pharma Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.10.5 SGD Pharma Recent Developments
  • 7.11 Nipro
    • 7.11.1 Nipro Profile
    • 7.11.2 Nipro Main Business
    • 7.11.3 Nipro Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.11.4 Nipro Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Nipro Recent Developments
  • 7.12 Shandong Weigao Group
    • 7.12.1 Shandong Weigao Group Profile
    • 7.12.2 Shandong Weigao Group Main Business
    • 7.12.3 Shandong Weigao Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.12.4 Shandong Weigao Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Shandong Weigao Group Recent Developments
  • 7.13 BD
    • 7.13.1 BD Profile
    • 7.13.2 BD Main Business
    • 7.13.3 BD Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.13.4 BD Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.13.5 BD Recent Developments
  • 7.14 HySum
    • 7.14.1 HySum Profile
    • 7.14.2 HySum Main Business
    • 7.14.3 HySum Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.14.4 HySum Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.14.5 HySum Recent Developments
  • 7.15 Chengdu Jingu Pharma-Pack Co.,Ltd
    • 7.15.1 Chengdu Jingu Pharma-Pack Co.,Ltd Profile
    • 7.15.2 Chengdu Jingu Pharma-Pack Co.,Ltd Main Business
    • 7.15.3 Chengdu Jingu Pharma-Pack Co.,Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.15.4 Chengdu Jingu Pharma-Pack Co.,Ltd Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Chengdu Jingu Pharma-Pack Co.,Ltd Recent Developments
  • 7.16 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd
    • 7.16.1 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Profile
    • 7.16.2 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Main Business
    • 7.16.3 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.16.4 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd Recent Developments
  • 7.17 Gerresheimer Shuangfeng
    • 7.17.1 Gerresheimer Shuangfeng Profile
    • 7.17.2 Gerresheimer Shuangfeng Main Business
    • 7.17.3 Gerresheimer Shuangfeng Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.17.4 Gerresheimer Shuangfeng Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Gerresheimer Shuangfeng Recent Developments
  • 7.18 Jinghua Group
    • 7.18.1 Jinghua Group Profile
    • 7.18.2 Jinghua Group Main Business
    • 7.18.3 Jinghua Group Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.18.4 Jinghua Group Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Jinghua Group Recent Developments
  • 7.19 Linuo Pharmaceutical Packaging
    • 7.19.1 Linuo Pharmaceutical Packaging Profile
    • 7.19.2 Linuo Pharmaceutical Packaging Main Business
    • 7.19.3 Linuo Pharmaceutical Packaging Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.19.4 Linuo Pharmaceutical Packaging Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.19.5 Linuo Pharmaceutical Packaging Recent Developments
  • 7.20 Jiyuan Zhengyu
    • 7.20.1 Jiyuan Zhengyu Profile
    • 7.20.2 Jiyuan Zhengyu Main Business
    • 7.20.3 Jiyuan Zhengyu Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.20.4 Jiyuan Zhengyu Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.20.5 Jiyuan Zhengyu Recent Developments
  • 7.21 EHUA
    • 7.21.1 EHUA Profile
    • 7.21.2 EHUA Main Business
    • 7.21.3 EHUA Pharmaceutical Primary Inner Packaging Products, Services and Solutions
    • 7.21.4 EHUA Pharmaceutical Primary Inner Packaging Revenue (US$ Million) & (2020-2025)
    • 7.21.5 EHUA Recent Developments

8 Industry Chain Analysis

  • 8.1 Pharmaceutical Primary Inner Packaging Industrial Chain
  • 8.2 Pharmaceutical Primary Inner Packaging Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pharmaceutical Primary Inner Packaging Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pharmaceutical Primary Inner Packaging Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제